Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: Is the sigma receptor involved?

被引:18
作者
Schuld, A [1 ]
Archelos, JJ [1 ]
Friess, E [1 ]
机构
[1] Max Planck Inst Psychiat, D-80804 Munich, Germany
关键词
D O I
10.1097/00004714-200010000-00014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:579 / 580
页数:2
相关论文
共 7 条
[1]   MODIFICATION OF THE N-METHYL-D-ASPARTATE RESPONSE BY ANTIDEPRESSANT SIGMA-RECEPTOR LIGANDS [J].
BERGERON, R ;
DEBONNEL, G ;
DEMONTIGNY, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 240 (2-3) :319-323
[2]   Visual hallucinations associated with fluoxetine and sertraline [J].
Bourgeois, JA ;
Thomas, D ;
Johansen, T ;
Walker, DM .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (06) :482-483
[3]   Open clinical trial on the sigma ligand panamesine in patients with schizophrenia [J].
Frieboes, RM ;
Murck, H ;
Wiedemann, K ;
Holsboer, F ;
Steiger, A .
PSYCHOPHARMACOLOGY, 1997, 132 (01) :82-88
[4]   SEROTONIN REUPTAKE INHIBITORS, PARANOIA, AND THE VENTRAL BASAL GANGLIA [J].
LAUTERBACH, EC .
CLINICAL NEUROPHARMACOLOGY, 1991, 14 (06) :547-555
[5]  
Popli A P, 1997, Ann Clin Psychiatry, V9, P15, DOI 10.1023/A:1026274123689
[6]   An open trial of adjunctive sertraline in the treatment of chronic schizophrenia [J].
Thakore, JH ;
Berti, C ;
Dinan, TG .
ACTA PSYCHIATRICA SCANDINAVICA, 1996, 94 (03) :194-197
[7]  
Zanardi R, 1996, AM J PSYCHIAT, V153, P1631